N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide
TL;DR: N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide (CAS 389075-79-0) is a chemical compound with molecular formula C25H20N4O4 and molecular weight 440.15 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[(E)-[3-(1H-benzimidazol-2-yl)-8-methoxychromen-2-ylidene]amino]-4-methoxybenzamide
Also Known As: N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide, N-[(E)-[3-(1H-benzimidazol-2-yl)-8-methoxychromen-2-ylidene]amino]-4-methoxybenzamide, F0803-0061, (E)-N'-(3-(1H-benzo[d]imidazol-2-yl)-8-methoxy-2H-chromen-2-ylidene)-4-methoxybenzohydrazide, N'-[3-(1H-benzimidazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide
| Molecular Formula | C25H20N4O4 |
|---|---|
| Molecular Weight | 440.15 g/mol |
| LogP | 4.239 |
| Topological Polar Surface Area | 101.74 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Exact Mass | 440.14847 |
| Heavy Atoms | 33 |
| Complexity | 1501.1965 |
Chemical Identifiers
| CAS Number | 389075-79-0 |
|---|---|
| SMILES | COC1=CC=C(C=C1)C(=O)N/N=C/2\C(=CC3=C(O2)C(=CC=C3)OC)C4=NC5=CC=CC=C5N4 |
Product Overview
N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide (CAS 389075-79-0), with molecular formula C25H20N4O4 and molecular weight 440.15 g/mol. IUPAC: N-[(E)-[3-(1H-benzimidazol-2-yl)-8-methoxychromen-2-ylidene]amino]-4-methoxybenzamide.
Chemical Property Profile of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide
Property Insights of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide
The XLogP value of 4.239 indicates that N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 101.74 Ų falls within the moderate polarity range, balancing permeability and solubility for N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide. Following Lipinski's Rule of Five, N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide has 2 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide?
The CAS number of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide is 389075-79-0.
What is the molecular formula of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide?
The molecular formula of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide is C25H20N4O4.
What is the molecular weight of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide?
The molecular weight of N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide is 440.15 g/mol.
Where can I buy N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide?
You can request a quote for N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide?
Yes, KEHONG BIO provides custom synthesis services for N'-[(2E)-3-(1H-1,3-benzodiazol-2-yl)-8-methoxy-2H-chromen-2-ylidene]-4-methoxybenzohydrazide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.